Global High-Priority Regulatory Events — December 18, 2025

19-12-2025

Churchill Capital Corp XI filed a multi-item Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered equity sales (Item 3.02), director/officer changes and compensatory arrangements (Item 5.02), amendments to articles/bylaws (Item 5.03), other events (Item 8.01), and exhibits (Item 9.01). No transaction values, financial metrics, or specific details disclosed. Likely SPAC-related activity but analysis limited to item disclosures.

• ·Multi-item mandatory 8-K filing; items include material agreement, equity sales, governance/officer changes.
• ·Core event: Entry into material definitive agreement (Item 1.01), with supporting disclosures; quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
• ·Filed same day as event date; compliance with 4-business-day rule presumed.

19-12-2025

SAFE & GREEN HOLDINGS CORP. filed an 8-K on December 19, 2025, announcing completion of an acquisition or disposition of assets (Item 2.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). No specific details on parties, deal structure, valuation, or quantitative metrics are disclosed in the provided filing summary. Analysis limited to item disclosures only.

• ·Completion of acquisition or disposition of assets confirmed.
• ·New direct financial obligation or off-balance sheet arrangement created.
• ·Financial statements and exhibits filed; all other transaction details NOT_DISCLOSED.

19-12-2025

Krispy Kreme, Inc. filed a Form 8-K on December 19, 2025 (AccNo: 0001857154-25-000143), reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This appears to be a multi-item mandatory filing filed on the event date.

• ·Specific Items reported: 1.01 (Entry into Material Definitive Agreement), 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event is entry into a material definitive agreement, details NOT_DISCLOSED
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED

19-12-2025

Moody's Corp filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits, but no specific details on positions, reasons, or individuals are provided. Quantitative data including transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer-related change (departure, election, appointment, or compensatory arrangements)
• ·Filed timely on 2025-12-19 per SEC requirements
• ·No details on key position, internal/external hire, reasons, or board impacts disclosed

19-12-2025

Better Home & Finance Holding Co filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements) and Item 7.01 (Regulation FD Disclosure). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis limited to disclosed Items; all other facts NOT_DISCLOSED.

• ·Item 5.02 triggered: Involves officer departure, election, appointment, or compensatory arrangements
• ·Item 7.01: Regulation FD Disclosure included
• ·No names, positions, reasons, or numerical data (e.g., shares, compensation) disclosed

19-12-2025

filed Insolvency on December 19, 2025 - ITC Ltd (500875) - Voluntary Liquidation of Prag Agro Farm Limited, a wholly owned subsidiary

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·ITC Ltd (500875) - Voluntary Liquidation of Prag Agro Farm Limited, a wholly owned subsidiary

19-12-2025

filed Insolvency on December 19, 2025 - Megasoft Ltd (532408) - Final Order dated December 16, 2025 passed by the Hon''ble NCLT, Chennai Bench for sanctioning the Scheme of Amalgamation a...

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·Megasoft Ltd (532408) - Final Order dated December 16, 2025 passed by the Hon''ble NCLT, Chennai Bench for sanctioning the Scheme of Amalgamation amongst Sigma Advanced Systems Private Limited and Megasoft Limited

19-12-2025

MANGOCEUTICALS, INC. filed Form 8-K on 2025-12-19 (AccNo: 0001493152-25-028444) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, or financials are disclosed in the summary. Analysis limited to item disclosures; full filing review needed for materiality assessment.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (per Item 1.01)
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

19-12-2025

filed Administration on December 19, 2025 - Notice of Executive Chair Collar Arrangement

• ·Filing Type: Administration
• ·Priority: HIGH
• ·Notice of Executive Chair Collar Arrangement

19-12-2025

filed Insolvency on December 19, 2025 - Triveni Engineering & Industries Ltd (532356) - Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015- Receipt of Order passed by the...

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·Triveni Engineering & Industries Ltd (532356) - Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015- Receipt of Order passed by the Hon''ble NCLT, Allahabad Bench in respect of Composite Scheme of Arrangement amongst Triveni Engineer

19-12-2025

filed Insolvency on December 19, 2025 - Sir Shadi Lal Enterprises Ltd (532879) - Intimation of NCLT order dated 16.12.2025

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·Sir Shadi Lal Enterprises Ltd (532879) - Intimation of NCLT order dated 16
• ·12

19-12-2025

filed Insolvency on December 19, 2025 - DCM Shriram Ltd (523367) - Liquidation of wholly owned step down subsidiary of the Company.

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·DCM Shriram Ltd (523367) - Liquidation of wholly owned step down subsidiary of the Company

19-12-2025

filed Insolvency on December 19, 2025 - Cian Healthcare Ltd (542678) - Approval of the Resolution Plan by Hon''ble National Company Law Tribunal ("NCLT") of Cian Healthcare Limited. Furth...

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·Cian Healthcare Ltd (542678) - Approval of the Resolution Plan by Hon''ble National Company Law Tribunal ("NCLT") of Cian Healthcare Limited
• ·Further please find attached herewith the Specific features and details of the resolution

19-12-2025

Rocky Mountain Chocolate Factory, Inc. filed a multi-item Form 8-K on December 19, 2025, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and departures/elections/appointments of directors/officers with compensatory arrangements (Item 5.02), along with exhibits (Item 9.01). No specific transaction details, values, or financial impacts are disclosed in the summary. This filing signals potential strategic and governance changes requiring follow-up for investment decisions.

• ·Multi-item 8-K filing: Items 1.01 (material agreement), 3.02 (unregistered equity sales), 5.02 (officer/director changes), 9.01 (exhibits)
• ·Core events involve a material agreement and equity issuance, with leadership transitions; all quantitative data (transaction value, share count, etc.) NOT_DISCLOSED
• ·Compliance with 8-K timing appears met (filed same day as event), but voluntary/mandatory status and details NOT_DISCLOSED

19-12-2025

Activate Energy Acquisition Corp. filed an 8-K on December 19, 2025, disclosing under Item 5.02 departures or elections of directors/officers and compensatory arrangements, with exhibits under Item 9.01. No merger/acquisition details, deal structure, parties, valuation, or quantitative data are explicitly stated in the filing summary. This appears unrelated to a confirmed M&A event based on disclosed items.

• ·Item 5.02: Reports personnel changes (directors/officers departures, elections, compensatory arrangements) - no specifics provided.
• ·Item 9.01: Financial statements and exhibits filed - contents NOT_DISCLOSED.
• ·No transaction value, share count, percentage changes, or financial metrics (revenue/EBITDA/EPS) mentioned: all NOT_DISCLOSED.

19-12-2025

Compass Minerals International Inc filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure/Election/Appointment of Officers/Directors), with Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the officer's position, nature of change (appointment/resignation), reasons, or quantitative data are provided in the summary. Filing appears timely and routine.

• ·Item 5.02 indicates officer or director change; key position, type (appointment/resignation), reason, and timing NOT_DISCLOSED
• ·Item 7.01: Regulation FD Disclosure (content NOT_DISCLOSED)
• ·Item 9.01: Financial Statements and Exhibits (details NOT_DISCLOSED); quantitative data (transaction value, share count, percentages, financial metrics) all NOT_DISCLOSED

19-12-2025

Legacy Housing Corp filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the position affected, individual involved, nature of change (appointment or resignation), reasons, or quantitative data are provided in the summary. Analysis is limited to metadata, with all key facts NOT_DISCLOSED.

• ·Item 5.02 disclosure filed on 2025-12-19 via SEC (AccNo: 0001104659-25-122626).
• ·Event type: Officer Change; no details on key position (CEO/CFO/COO etc.), internal/external, or reasons stated.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

19-12-2025

Bain Capital GSS Investment Corp. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 filing indicates officer change or compensatory arrangement, but key details (position, name, reason) NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·Routine 8-K disclosure compliant with SEC timing, but lacks materiality for investment decisions.

19-12-2025

Northern Technologies International Corp filed an 8-K on 2025-12-19 disclosing entry into a Material Definitive Agreement under Item 1.01 with exhibits under Item 9.01. No details on the agreement, transaction value, or financial impacts are provided. Analysis limited to filing summary.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; mandatory disclosure for Item 1.01
• ·Core event: Material Definitive Agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED

19-12-2025

filed Insolvency on December 19, 2025 - Embassy Developments Ltd (532832) - Corrigendum to letter dated December 17, 2025 in respect of the inclusion of the Company''s scrip under Additio...

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·Embassy Developments Ltd (532832) - Corrigendum to letter dated December 17, 2025 in respect of the inclusion of the Company''s scrip under Additional Surveillance Measures ("ASM Framework") under Insolvency and Bankruptcy Code, 2016 ("I

19-12-2025

Ryder System Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure, with all key leadership and governance details NOT_DISCLOSED.

• ·Item 5.02 confirms an officer change event, but position (e.g., CEO/CFO), type (appointment/resignation), and reasons (e.g., retirement) are NOT_DISCLOSED.
• ·Items 7.01 and 9.01 indicate additional Reg FD disclosure and exhibits, but content NOT_DISCLOSED.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned; all NOT_DISCLOSED.

19-12-2025

Golden Matrix Group, Inc. filed an 8-K on 2025-12-19 (AccNo: 0001477932-25-009059) disclosing Item 5.02 on departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the available summary. Analysis limited to filing metadata.

• ·Item 5.02 event filed timely (within SEC 4-business-day requirement)
• ·Key position, appointment/resignation details: NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages: NOT_DISCLOSED)

19-12-2025

BeOne Medicines Ltd. filed an 8-K on December 19, 2025, reporting under Item 1.02 the termination of a material definitive agreement. No details on the agreement's nature, value, or financial impacts are disclosed. This event is inherently negative but lacks quantification for precise assessment.

• ·Item 1.02: Termination of a Material Definitive Agreement
• ·No transaction value, share count, or financial metrics disclosed
• ·Single-item 8-K filing; sector not specified

19-12-2025

Cannabist Co Holdings Inc. filed a Form 8-K on 2025-12-19 reporting entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific details on agreements, parties, values, or impacts are disclosed in the provided summary. This multi-item filing signals potentially offsetting strategic changes but lacks quantification.

• ·Multi-item filing: Items 1.01, 1.02, 7.01, 9.01 – mandatory for material events.
• ·Core event: Entry and termination of material agreements; all transaction details NOT_DISCLOSED.
• ·Timing compliance and financial impacts NOT_DISCLOSED.

19-12-2025

COTY INC. filed a Form 8-K on 2025-12-19 reporting Items 1.01 (Entry into Material Definitive Agreement), 2.06 (Material Impairments), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, financial impacts, or quantitative metrics are disclosed in the provided summary. This multi-item filing signals potentially significant developments, primarily negative due to material impairments.

• ·Multi-item 8-K filing: Items 1.01, 2.06, 8.01, 9.01
• ·Core events: Material agreement and impairments (exact nature NOT_DISCLOSED)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

19-12-2025

ArrowMark Financial Corp. filed a Form 8-K on December 19, 2025 (AccNo: 0001104659-25-122683), reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or financials disclosed in the provided summary. All transaction values, impacts, and quantitative data are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Item 1.01 signals entry into Material Definitive Agreement (core event unspecified)
• ·No numerical data (e.g., transaction value, share count) or financial impacts extracted

19-12-2025

Axos Financial, Inc. disclosed an officer change via Form 8-K on December 19, 2025, under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. No specific details on the officer, position, reason, or terms are provided in the filing summary. This is a routine SEC disclosure with no quantified financial or strategic impacts stated.

• ·Item 5.02 filing indicates officer-related change (departure, election, appointment, or compensation).
• ·Filed within SEC 8-K requirements (within 4 business days).
• ·No details on key position, internal/external hire, reason, or board impact disclosed.

19-12-2025

BrightSpire Capital, Inc. filed Form 8-K on 2025-12-19 disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, values, or impacts are stated in the provided summary. This is a multi-item mandatory filing compliant with SEC 8-K requirements.

• ·Multi-item filing: Items 1.01, 2.03, 9.01 reported
• ·Core event: Entry into material definitive agreement and new financial obligation
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

19-12-2025

NATIONAL HEALTH INVESTORS INC filed an 8-K on 2025-12-19 disclosing Item 5.02 on departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data provided in the summary. Analysis limited to filing metadata; critical details NOT_DISCLOSED.

• ·Item 5.02 event: Potential officer departure, appointment, or compensatory arrangement
• ·Filed timely per SEC 8-K requirements (within 4 business days)
• ·No names, positions, reasons, or financial metrics disclosed

19-12-2025

abrdn Income Credit Strategies Fund filed a multi-item 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation/bylaws or fiscal year change (Item 5.03), and exhibits (Item 9.01). No specific transaction values, share counts, or financial metrics are disclosed in the provided summary. Analysis limited to item triggers; full filing review required for details.

• ·Multi-item mandatory 8-K filing with Items 1.01, 3.02, 5.03, 9.01
• ·Core events: material agreement, unregistered equity sales, governance/fiscal changes
• ·All quantitative data (transaction value, shares, percentages) NOT_DISCLOSED

19-12-2025

ECD Automotive Design, Inc. filed a multi-item Form 8-K on December 19, 2025 (AccNo: 0001437749-25-038336), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors/Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, financial metrics, or quantitative data provided in summary. Analysis limited; full filing required for deeper insights.

• ·Multi-item 8-K filing: Items 3.03, 5.02, 7.01, 9.01
• ·Potential governance changes (rights modifications, director/officer shifts)
• ·Timely filing on event date; voluntary/mandatory mix per items

19-12-2025

American Electric Power Co Inc filed an 8-K on 2025-12-19 disclosing Item 5.02 regarding departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific names, positions, reasons, or quantitative details provided in the summary. Event appears routine with neutral implications absent further disclosure.

• ·Item 5.02 filing on officer/director changes or compensatory arrangements
• ·No key position (CEO/CFO/etc.), appointment/resignation details, or reasons stated
• ·No quantitative data (transaction values, shares, percentages, financial metrics) disclosed

19-12-2025

filed IPO Listing on December 19, 2025 - Fortune International Ltd (530213) - Pursuant to Reg 6 of SEBI(Delisting of Equity shares) Regulations, 2021, plz find the enclosed newspaper adver...

• ·Filing Type: IPO Listing
• ·Priority: HIGH
• ·Fortune International Ltd (530213) - Pursuant to Reg 6 of SEBI(Delisting of Equity shares) Regulations, 2021, plz find the enclosed newspaper advertisement made in the Financial express (English), Jansatta (Hindi) and Arthik lipi (Calcutt

19-12-2025

Peabody Energy Corp filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment/Compensatory Arrangements). Item 9.01 lists financial statements and exhibits. No specifics on position, individual, reason, or quantitative data are disclosed.

• ·Item 5.02 indicates potential departure, election, appointment, or compensatory arrangement for officers/directors.
• ·Item 9.01 references exhibits, but contents NOT_DISCLOSED.
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

19-12-2025

Abacus Global Management, Inc. filed a Form 8-K on December 19, 2025, reporting under Item 3.01 a notice of delisting or failure to satisfy continued listing rules, alongside Item 7.01 Regulation FD disclosure and Item 9.01 exhibits. This indicates a material adverse event involving delisting from US markets. No specific reasons, financial impacts, or quantitative details are disclosed in the provided filing summary.

• ·Multi-item 8-K filing: Items 3.01 (delisting notice), 7.01 (Reg FD), 9.01 (exhibits)
• ·Core event: Notice of delisting or listing rule failure; timing aligns with filing date
• ·All transaction values, share counts, financial metrics: NOT_DISCLOSED

19-12-2025

Galectin Therapeutics Inc. filed an 8-K on December 19, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No details on the agreement terms, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing structure; critical details NOT_DISCLOSED.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into undisclosed Material Definitive Agreement.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

19-12-2025

Hawkins Inc filed an 8-K on 2025-12-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data provided in the filing summary. Analysis limited to disclosed header information.

• ·Item 5.02 filing for officer/director changes or compensatory arrangements
• ·Filed 2025-12-19 (AccNo: 0000046250-25-000059, Size: 138 KB)
• ·Sector: NOT_DISCLOSED; no names, positions, reasons, or quantitative metrics mentioned

19-12-2025

RMR Group Inc. filed an 8-K on December 19, 2025 (AccNo: 0001104659-25-122783), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to absence of key facts.

• ·Item 5.02 disclosure on unspecified officer change.
• ·Filed on 2025-12-19, compliant with SEC 8-K timing.
• ·No details on position (e.g., CEO/CFO), type (appointment/resignation), or reasons provided (all NOT_DISCLOSED).

19-12-2025

Bark, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001628280-25-058100), reporting Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule and Item 8.01 Other Events. This signals a delisting from US markets due to non-compliance with listing standards. No specific details on reasons, financial impacts, or transaction values are disclosed.

• ·8-K items: 3.01 (delisting notice) and 8.01 (other events); multi-item filing.
• ·Core event: Notice of delisting or listing rule failure; voluntary/mandatory not specified.
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.

19-12-2025

USBC, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001161697-25-000473), reporting entry into a Material Definitive Agreement under Item 1.01 and attaching exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED.

• ·8-K reports Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into a Material Definitive Agreement (details NOT_DISCLOSED).
• ·Quantitative data (transaction value, share count, financial metrics): all NOT_DISCLOSED.

19-12-2025

Boxlight Corp filed a multi-item Form 8-K on December 19, 2025, disclosing Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of modifications, amendments, or disclosures are provided in the summary, limiting analysis depth. All quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering security holder rights changes, governance amendments, and Reg FD info
• ·Mandatory disclosure under SEC rules for material events; filing timeliness not assessable without event date
• ·Core event involves governance changes; strategic/financial impacts NOT_DISCLOSED

19-12-2025

Mirum Pharmaceuticals, Inc. filed a Form 8-K on December 19, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses a material event but lacks specific details on transaction terms or financial impacts. All quantitative data such as transaction value, share count, or percentage changes are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 3.02, 7.01, 9.01.
• ·Core events: Material definitive agreement and unregistered equity sales.
• ·No numerical values or detailed impacts explicitly stated.

19-12-2025

BioMarin Pharmaceutical Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to reported items; full filing review required for deeper insights.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into material definitive agreement (NOT_DISCLOSED details)
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

19-12-2025

Trio-Tech International filed a Form 8-K on December 19, 2025 (AccNo: 0001437749-25-038362), reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details on the nature of modifications, amendments, or disclosures are provided in the summary. All quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering shareholder rights changes, governance amendments, Reg FD info, and exhibits.
• ·Filed same day as event date (2025-12-19), likely within 4-business-day requirement.
• ·Core event details, dollar values, and financial impacts NOT_DISCLOSED; analysis limited to item disclosures.

19-12-2025

EQV Ventures Acquisition Corp. filed an 8-K on December 19, 2025, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), disclosing a merger/acquisition event. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Analysis is limited to metadata, with all quantitative and qualitative deal terms NOT_DISCLOSED.

• ·Filing references merger/acquisition event via Items 8.01 and 9.01.
• ·No parties, valuation, structure, or synergies disclosed.
• ·Sector not specified; requires full filing review for details.

19-12-2025

filed Insolvency on December 19, 2025 - Alps Industries Ltd (530715) - Outcome of the meeting the Board of Directors of ALPS Industries Limited (the 'Company') intimating the Issuance and...

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·Alps Industries Ltd (530715) - Outcome of the meeting the Board of Directors of ALPS Industries Limited (the 'Company') intimating the Issuance and allotment of Equity Shares pursuant to the implementation of Resolution Plan as appr

19-12-2025

Amicus Therapeutics, Inc. filed a Form 8-K on December 19, 2025, disclosing Item 1.01 (Entry into Material Definitive Agreement), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, or financial impacts provided in the summary. Analysis is constrained by lack of filing content; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 5.03, 7.01, 9.01 reported.
• ·Mandatory disclosure likely due to material agreement and governance changes.
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); critical details missing.

19-12-2025

Liberty Latin America Ltd. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD Disclosure (Item 7.01) and Financial Statements/Exhibits (Item 9.01). Specific details including the key position affected, appointment/resignation status, reasons, or names are NOT_DISCLOSED. No quantitative data such as transaction values, share counts, or financial metrics are mentioned.

• ·Item 5.02 indicates officer change event (departure, election, appointment, or compensatory arrangements), but specifics NOT_DISCLOSED.
• ·Includes Reg FD disclosure (Item 7.01) suggesting potential material non-public information shared.
• ·Filed within SEC 8-K requirements; sector not specified.

19-12-2025

XCel Brands, Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits attached (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item mandatory filing with limited visibility into implications.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits).
• ·Core events involve a material agreement and equity sales, but transaction details, values, and impacts NOT_DISCLOSED.
• ·Filed same day as event; compliance with 4-business-hour rule NOT_DISCLOSED.

19-12-2025

Actelis Networks Inc filed a Form 8-K on December 19, 2025, disclosing entry into a material definitive agreement under Item 1.01 and attaching financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis is limited to filing metadata, with all quantitative data NOT_DISCLOSED.

• ·8-K reports Items 1.01 (Material Definitive Agreement) and 9.01 (Exhibits).
• ·Multi-item filing; core event is entry into undisclosed material agreement.
• ·No numerical data (e.g., transaction value, shares: NOT_DISCLOSED); requires full filing review.

19-12-2025

HERITAGE FINANCIAL CORP /WA/ filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. This limits assessment of governance or market implications.

• ·Item 5.02 indicates a change involving directors or certain officers, including possible compensatory arrangements.
• ·Filed timely per SEC requirements (within 4 business days).
• ·No quantitative data (e.g., transaction values, share counts, financial metrics) disclosed.

19-12-2025

Flag Ship Acquisition Corp filed an 8-K on 2025-12-19 reporting submission of matters to a vote of security holders (Item 5.07) and financial statements/exhibits (Item 9.01) in a merger/acquisition context. No specific deal details, parties, values, or vote outcomes explicitly stated. Sector not specified.

• ·Item 5.07 discloses shareholder vote submission, likely merger-related for SPAC.
• ·Item 9.01 includes financial statements and exhibits.
• ·All quantitative data (transaction value, shares, percentages, metrics) NOT_DISCLOSED.

19-12-2025

WYTEC INTERNATIONAL INC disclosed an officer change via 8-K filed on 2025-12-19 under Item 5.02 (Departure/Election/Appointment of Officers). No specifics on position, individual, reason, or compensatory arrangements provided in summary. Item 9.01 references exhibits, but details NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer departure, election, or appointment; no key position (CEO/CFO/COO) specified.
• ·Timely SEC disclosure within 4 business days compliant.
• ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED.

19-12-2025

Marvion Inc. filed a Form 8-K on December 19, 2025 (AccNo: 0001683168-25-009274), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, parties, terms, or financial impacts are disclosed in the provided summary. All quantitative data such as transaction value, share count, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement) and 9.01 (Exhibits)
• ·Mandatory disclosure of material event; filed same day as event date
• ·No sector, transaction details, or numerical values provided; full filing review required

19-12-2025

AmBase Corp filed an 8-K on December 19, 2025 (AccNo: 0001140361-25-046179), reporting under Item 1.01 entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Full filing review required for accurate assessment.

• ·Items 1.01 and 9.01 reported; multi-item filing
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

19-12-2025

FIRST MID BANCSHARES, INC. filed an 8-K on 2025-12-19 disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on individuals, roles, reasons, or quantitative data are provided in the summary. Analysis is severely limited by absence of filing content, resulting in neutral implications.

• ·Item 5.02 disclosure on officer/director changes or compensatory arrangements
• ·All specifics (position, appointment/resignation, reasons, timing) NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED

19-12-2025

Axalta Coating Systems Ltd. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements) and exhibits under Item 9.01. No specific details on positions affected, appointment/resignation type, reasons, or quantitative data are provided in the summary. Analysis is limited; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 signals unspecified officer or director change or compensatory arrangement.
• ·Timely SEC filing (within 4 business days requirement).
• ·Quantitative data (transaction values, shares, percentages, financial metrics): NOT_DISCLOSED.

19-12-2025

Comfort Systems USA Inc filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election or Appointment; Compensatory Arrangements), alongside Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). Specific details on the officer's position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. This appears to be a routine leadership disclosure with neutral implications pending full filing review.

• ·Item 5.02: Officer change involving departure, election, appointment, or compensatory arrangements
• ·Item 7.01: Regulation FD disclosure made
• ·Filed December 19, 2025; AccNo: 0001104659-25-123112; no quantitative data (e.g., shares, values) disclosed

19-12-2025

Midland States Bancorp, Inc. filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, reason for change, or quantitative data are provided in the filing summary. This appears to be a routine disclosure with limited visibility into implications.

• ·Item 5.02 filing: Covers officer departures, elections, appointments, or compensatory arrangements.
• ·No details on key position (e.g., CEO, CFO), appointment/resignation status, or reasons stated.
• ·Filed timely per SEC requirements; sector not specified.

19-12-2025

Paramount Group, Inc. filed an 8-K on December 19, 2025, disclosing completion of an acquisition or disposition of assets (Item 2.01), notice of delisting (Item 3.01), material modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), and amendments to governing documents (Item 5.03). No specific details on parties, deal structure, valuation, or financial metrics are provided in the filing summary. This indicates a completed major corporate event involving change of control and potential end of public trading.

• ·Completion of acquisition/disposition confirmed (Item 2.01)
• ·Delisting or listing failure noticed (Item 3.01); change in control (Item 5.01)
• ·Governance changes including director/officer shifts, rights modifications, and charter/bylaw amendments (Items 3.03, 5.02, 5.03)

19-12-2025

Rhythm Pharmaceuticals, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001104659-25-123108), disclosing an Item 5.02 event involving departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis limited to header information; full filing review needed for completeness.

• ·Item 5.02: Covers officer/director departures, elections, appointments, or compensatory arrangements.
• ·Event filed timely on 2025-12-19 per SEC 8-K requirements (within 4 business days).
• ·All quantitative data (transaction values, share counts, percentages, financial metrics): NOT_DISCLOSED.

19-12-2025

Lifeward Ltd. filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements. No specific details on the officer's position, name, appointment/resignation status, or reasons are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer-related change (departure, election, appointment, or compensation), but key details NOT_DISCLOSED.
• ·No information on leadership position affected (e.g., CEO, CFO), internal/external hire, or timing provided.
• ·Sector not specified; no board composition, governance, or succession planning details disclosed.

19-12-2025

CF Industries Holdings, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or terms are provided in the filing summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer change or compensatory arrangement, but key position (e.g., CEO, CFO) is NOT_DISCLOSED.
• ·No reasons for change (e.g., resignation, appointment, retirement) or timing details stated.
• ·No governance, succession, board, or market impact specifics mentioned; all quantitative data NOT_DISCLOSED.

19-12-2025

Frontier Communications Parent, Inc. filed a Form 8-K on December 19, 2025, disclosing events under Items 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election/Appointment of Officers; Compensatory Arrangements), and 8.01 (Other Events). No specific details on officers, positions, reasons for changes, or quantitative data are provided in the filing summary. This indicates an officer change event but lacks material facts for deeper analysis.

• ·Item 5.02 signals potential departure, election, appointment of directors/officers, or compensatory arrangements.
• ·Item 3.02 reports unregistered sales of equity securities.
• ·Item 8.01 covers other unspecified events; no quantitative or named details disclosed.

19-12-2025

Ouster, Inc. filed an 8-K on 2025-12-19 reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; full filing review required for deeper insights.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement) and 9.01 (Exhibits)
• ·Core event: Entry into undisclosed Material Definitive Agreement
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED

19-12-2025

ETHZilla Corp filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure/Election of Officers or Compensatory Arrangements), alongside Item 7.01 (Reg FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Exhibits). No specific details on position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; all other facts NOT_DISCLOSED.

• ·Item 5.02 indicates officer change event, but key position (e.g., CEO/CFO), type (appointment/resignation), and reasons NOT_DISCLOSED.
• ·Additional disclosures under Items 7.01, 8.01, 9.01 suggest possible related events or exhibits, but content NOT_DISCLOSED.
• ·Timely SEC filing (within 4 business days); no quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED.

19-12-2025

Independent Bank Corp (/MI/) filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specifics on position, individual, reason, or quantitative data are provided.

• ·Item 5.02: Officer departure, election, appointment, or compensatory arrangements
• ·Filed 2025-12-19; AccNo: 0000039311-25-000105
• ·No details on key position, reason, internal/external, or board impact disclosed

19-12-2025

Profound Medical Corp. filed an 8-K on December 19, 2025, disclosing entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the available summary. Analysis is limited to filing metadata, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01); Item 1.01 indicates mandatory disclosure of a material definitive agreement.
• ·Core event: Entry into material definitive agreement (details NOT_DISCLOSED); timing of filing vs. event and business day compliance NOT_DISCLOSED.
• ·No revenue, balance sheet, or guidance impacts mentioned; quantitative extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

19-12-2025

Toll Brothers, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) with exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 disclosure indicates officer change or compensatory arrangement, but key details (position, internal/external, reason) NOT_DISCLOSED.
• ·Item 9.01 references financial statements/exhibits, content NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

19-12-2025

Sarepta Therapeutics filed an 8-K on December 19, 2025, reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with exhibits under Item 9.01. No specific details on the agreement, transaction value, or terms are disclosed in the provided summary. This multi-item filing signals a potentially significant corporate event, but analysis is limited without full filing content.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01.
• ·Core event involves material definitive agreement and new financial obligation.
• ·All quantitative data (transaction value, share count, etc.) NOT_DISCLOSED.

19-12-2025

New Fortress Energy Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement under Item 1.01 and including financial statements/exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This constitutes a mandatory disclosure of a material event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Filed same day as event (2025-12-19); timing within 4 business hours NOT_DISCLOSED.
• ·Core event: Entry into material definitive agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED.

19-12-2025

Nauticus Robotics, Inc. filed an 8-K on 2025-12-19 under Item 5.02 disclosing an officer change event involving potential departures, appointments, or compensatory arrangements. No specifics on positions affected, individuals, reasons, or quantitative data are stated in the provided summary. Analysis is limited to metadata, with all key details NOT_DISCLOSED.

• ·Item 5.02 filing confirms disclosure of officer/director change or compensatory arrangements per SEC requirements.
• ·Timely filing (same day as event date December 19, 2025) indicates regulatory compliance.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) or qualitative details (position, appointment/resignation, reasons) disclosed.

19-12-2025

UWM Holdings Corp filed a Form 8-K on December 19, 2025 (AccNo: 0001783398-25-000065), reporting entry into a material definitive agreement under Item 1.01, with financial statements and exhibits under Item 9.01. No details on the agreement's nature, terms, value, or impact are explicitly stated in the provided summary. This is a multi-item mandatory disclosure of a material event.

• ·Items reported: 1.01 (Entry into a Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Entry into unspecified material definitive agreement
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

19-12-2025

Hyperscale Data, Inc. filed a Form 8-K on December 19, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure, indicating a potentially significant but undisclosed event.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (Item 1.01)
• ·Filed December 19, 2025; AccNo: 0001214659-25-018293; sector NOT_DISCLOSED

19-12-2025

NCR Atleos Corp filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election; Compensatory Arrangements) and exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are provided in the summary. This limits analysis to procedural compliance with SEC disclosure requirements.

• ·Item 5.02 disclosure of officer change filed within standard 4-business-day window
• ·Item 9.01 includes exhibits (size 140 KB), content NOT_DISCLOSED
• ·All quantitative data (transaction value, share count, percentages, financial metrics) NOT_DISCLOSED

19-12-2025

ONE Gas, Inc. filed a Form 8-K on December 19, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial terms are provided in the summary. This is a multi-item mandatory filing signaling a significant corporate commitment.

• ·Reported Items: 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 9.01 (Exhibits)
• ·Core event: Entry into undisclosed material agreement creating financial obligation
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

19-12-2025

Q32 Bio Inc. filed an 8-K on December 19, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, but all specific details including position, appointment/resignation status, reasons, and quantitative data are NOT_DISCLOSED. No facts on leadership changes, governance impacts, or market implications can be extracted from the provided summary. Analysis limited to filing metadata; critical details missing.

• ·Item 5.02 filing on officer/director changes or compensatory arrangements
• ·No disclosure of key position affected, appointment/resignation, or reasons
• ·Quantitative data (transaction values, shares, percentages, financial metrics): NOT_DISCLOSED

19-12-2025

Rithm Capital Corp. filed an 8-K on December 19, 2025, announcing completion of an acquisition or disposition of assets (Item 2.01), with Regulation FD disclosure (Item 7.01) and financial exhibits (Item 9.01). Specific details on parties, structure, valuation, and quantitative metrics are NOT_DISCLOSED. Analysis limited to filing items; no deal rationale or impacts stated.

• ·Item 2.01 confirms completion of unspecified acquisition/disposition
• ·Item 7.01 provides Regulation FD disclosure (details NOT_DISCLOSED)
• ·Item 9.01 includes financial statements/exhibits (content NOT_DISCLOSED); all numerical data (value, shares, percentages) NOT_DISCLOSED

19-12-2025

Yelp Inc. filed an 8-K on December 19, 2025, reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided summary. Analysis is limited to item disclosures; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01 and 2.03.
• ·Core event involves a material definitive agreement creating a financial obligation.
• ·No dollar values, share counts, or financial metrics disclosed.

19-12-2025

Emmaus Life Sciences, Inc. filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 indicates financial statements and exhibits were included. No specific details on officer name, position, appointment/resignation, reasons, or quantitative data are disclosed in the provided summary.

• ·Item 5.02 filing signals officer change event, but key details (position, type, reason) NOT_DISCLOSED
• ·Timely SEC 8-K filing (within 4 business days requirement met)
• ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED

19-12-2025

Lakeside Holding Ltd filed a multi-item Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and officer/director changes including compensatory arrangements (Item 5.02). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Full filing review required for precise impacts.

• ·Multi-item mandatory 8-K filing: Items 1.01, 3.02, 5.02, 9.01
• ·Core events involve material agreement, equity sales, and leadership changes; all quantitative data NOT_DISCLOSED
• ·Timing compliant with 4-business-day window based on filing date matching event date

19-12-2025

LQR House Inc. filed an 8-K on December 19, 2025 (AccNo: 0001213900-25-123834), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 8.01, and 9.01.
• ·Item 1.01 indicates entry into a material definitive agreement (mandatory disclosure).
• ·Timing compliance and core event details NOT_DISCLOSED.

19-12-2025

HCI Group, Inc. filed an 8-K on December 19, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, per AccNo 0001193125-25-326799. No specific details on the officer, position, nature of change (appointment/resignation), reasons, or quantitative data are provided in the summary. Analysis limited to filing metadata; all key change details NOT_DISCLOSED.

• ·Item 5.02 disclosure on officer/director changes or compensatory arrangements
• ·Filed timely on 2025-12-19; no names, positions, or reasons stated
• ·No quantitative data (shares, values, percentages) extracted: all NOT_DISCLOSED

19-12-2025

Greenlane Holdings, Inc. filed an 8-K on December 19, 2025, disclosing an officer change or compensatory arrangement under Item 5.02 and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to metadata; critical details NOT_DISCLOSED.

• ·Item 5.02 filing indicates departure, election, appointment, or compensatory arrangements for directors/officers.
• ·Item 9.01 includes financial statements/exhibits (contents NOT_DISCLOSED).
• ·No names, positions, reasons, timing, or quantitative metrics (e.g., transaction value, share count) disclosed.

19-12-2025

PAR PACIFIC HOLDINGS, INC. filed a Form 8-K on 2025-12-19 reporting Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided summary. Core event involves a material agreement with financial obligations, but all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 9.01.
• ·Mandatory disclosure for material events; filed same day as event date.
• ·No quantitative data (transaction value, share count, financial metrics: all NOT_DISCLOSED).

19-12-2025

byNordic Acquisition Corp filed an 8-K on December 19, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), with exhibits attached (Item 9.01). No specific deal parties, structure, valuation, or quantitative details are provided in the filing summary. Analysis is limited due to lack of explicit data.

• ·Material definitive agreement entered (Item 1.01).
• ·Direct financial obligation created (Item 2.03).
• ·Financial statements/exhibits filed (Item 9.01); all other details NOT_DISCLOSED.

19-12-2025

ITHAX Acquisition Corp III filed an 8-K on December 19, 2025 (AccNo: 0001104659-25-123159), disclosing other events under Item 8.01 and financial statements/exhibits under Item 9.01 related to a merger/acquisition. No specific details on parties, structure, valuation, or terms are explicitly stated in the provided filing summary. All quantitative data and strategic rationale are NOT_DISCLOSED, limiting analysis to metadata.

• ·Event announced via Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Sector not specified; deal size, consideration, and parties NOT_DISCLOSED
• ·QUANTITATIVE DATA EXTRACTION: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

19-12-2025

PRO DEX INC filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure/Election of Officers), other events in Item 8.01, and exhibits in Item 9.01. No specific details on positions affected, appointment/resignation type, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details like officer names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 indicates officer change or compensatory arrangements; specifics NOT_DISCLOSED
• ·Items 8.01 and 9.01 noted but content NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·SEC compliance met via timely 8-K filing; no governance or market impact details available

19-12-2025

Kemper Corp filed an 8-K on 2025-12-19 under Item 5.02 disclosing an unspecified officer change, election, appointment, or compensatory arrangement, with Item 9.01 listing exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Event appears routine and informational pending full review.

• ·Item 5.02: Disclosure of departure/election/appointment of officers or directors, or compensatory arrangements
• ·Item 9.01: Financial statements and exhibits filed
• ·Filed timely (within SEC 4-business-day requirement for 8-K); no quantitative data extracted (all NOT_DISCLOSED)

19-12-2025

United Parks & Resorts Inc. filed an Item 5.02 8-K on December 19, 2025, disclosing a departure of directors/officers, election/appointment, or compensatory arrangements, but specific details such as names, positions, reasons, or quantitative data are NOT_DISCLOSED. No financial metrics, share counts, or transaction values mentioned. Analysis limited to filing metadata.

• ·Item 5.02: Departure/Election/Appointment of Certain Officers/Directors or Compensatory Arrangements
• ·Filed: 2025-12-19 (AccNo: 0001193125-25-326904)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED
• ·Sector: NOT_DISCLOSED

19-12-2025

Rithm Property Trust Inc. announced the completion of an acquisition or disposition of assets via 8-K filing on December 19, 2025 (Item 2.01). Item 9.01 provides financial statements and exhibits. No specific details on parties, structure, valuation, or quantitative metrics are disclosed.

• ·Item 2.01 confirms deal completion (acquisition or disposition)
• ·Item 9.01 includes financial statements and exhibits for review
• ·All quantitative data (transaction value, shares, percentages) NOT_DISCLOSED

19-12-2025

InspireMD, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, or reasons provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics: NOT_DISCLOSED.

• ·Item 5.02 indicates a leadership change event, but key details (position, internal/external, reason, timing) NOT_DISCLOSED.
• ·Item 9.01 references exhibits, but contents and any financials NOT_DISCLOSED.
• ·Sector not specified; no board composition, governance, or market impact details available.

19-12-2025

SELECT MEDICAL HOLDINGS CORP filed an 8-K on 2025-12-19 under Item 5.02 disclosing a departure of directors/officers, election/appointment, or compensatory arrangements, with exhibits under Item 9.01. No specifics on officer name, position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing headers.

• ·Item 5.02 triggered for officer/director changes or compensatory arrangements (FACTS)
• ·Item 9.01 for financial statements/exhibits (FACTS)
• ·No details on key position, reason, internal/external hire, or quantitative metrics (NOT_DISCLOSED)

19-12-2025

ACCESS Newswire Inc. filed an 8-K on December 19, 2025 (AccNo: 0001683168-25-009281), disclosing an Item 5.02 event related to departure, election, or appointment of directors/officers or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data provided in the available summary. Sector not specified.

• ·Item 5.02 filing indicates officer or director change or compensatory arrangement
• ·Filed on 2025-12-19, compliant with SEC 8-K timing (within 4 business days)
• ·Critical details such as key position, appointment/resignation status, and reasons NOT_DISCLOSED

19-12-2025

My Size, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001493152-25-028559) disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the summary. Analysis is severely limited by absence of filing content, resulting in neutral implications.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but all specifics (names, positions, reasons) NOT_DISCLOSED
• ·Event date: December 19, 2025; sector NOT_DISCLOSED
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

19-12-2025

ACADIA REALTY TRUST filed an 8-K on 2025-12-19 disclosing an officer change under Item 5.02 (Departure/Election of Officers), Regulation FD disclosure in Item 7.01, and exhibits in Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited without full filing content.

• ·Item 5.02 indicates officer change event
• ·Filed 2025-12-19; AccNo: 0001193125-25-326893
• ·No details on key position, reason, or quantitative metrics (all NOT_DISCLOSED)

19-12-2025

RxSight, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001193125-25-326889), disclosing Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited to metadata; all other details are NOT_DISCLOSED.

• ·Item 5.02 filing on officer/director changes or compensatory arrangements
• ·Filed timely on 2025-12-19 per SEC requirements
• ·No names, positions, reasons, transaction values, share counts, or financial metrics disclosed

19-12-2025

Dycom Industries Inc filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, reason for change, or quantitative data are provided in the summary. Analysis limited to filing metadata; critical facts NOT_DISCLOSED.

• ·Event: Officer Change (Item 5.02)
• ·Filed: 2025-12-19, AccNo: 0001193125-25-326900
• ·No quantitative data (Transaction Value: NOT_DISCLOSED, Share Count: NOT_DISCLOSED, etc.)
• ·Sector: NOT_DISCLOSED

19-12-2025

Repare Therapeutics Inc. disclosed an officer change via Form 8-K on December 19, 2025, under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the affected position, individual, reason, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 filing indicates officer-related change, but key position (e.g., CEO, CFO) is NOT_DISCLOSED.
• ·No reasons, timing, or succession details stated.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): all NOT_DISCLOSED.

19-12-2025

Martin Marietta Materials Inc filed a Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), with exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are disclosed in the provided summary. Analysis is limited to filing items; critical details NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01.
• ·Core event involves material agreement and new financial obligation.
• ·No numerical data (transaction value, shares, metrics) disclosed.

19-12-2025

Keurig Dr Pepper Inc. filed an 8-K on 2025-12-19 reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), with exhibits under Item 9.01. No specific transaction details, dollar values, or terms are disclosed in the provided summary. This indicates a potentially significant financing or contractual event requiring further review of exhibits.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01
• ·Core event: Material definitive agreement creating financial obligation; all quantitative data NOT_DISCLOSED
• ·Compliance with 8-K requirements presumed; timing and details NOT_DISCLOSED

19-12-2025

Vaxcyte, Inc. disclosed an officer change via Form 8-K on December 19, 2025, under Item 5.02 covering departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits, but no specific details on positions, reasons, or individuals are provided. Filing appears compliant with SEC requirements, with no quantitative data or material facts disclosed.

• ·Item 5.02: Disclosure of officer departure, election, appointment, or compensatory arrangements (details NOT_DISCLOSED).
• ·Item 9.01: Financial statements and exhibits filed (contents NOT_DISCLOSED).
• ·No names, positions, reasons, or numerical data explicitly stated; routine SEC disclosure.

19-12-2025

Clear Channel Outdoor Holdings, Inc. filed a Form 8-K on December 19, 2025, disclosing Item 5.02 on departures of directors/officers, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific officer names, positions, reasons, or quantitative details are provided.

• ·Item 5.02 covers potential officer/departure, appointment, or compensatory arrangements
• ·Filed 2025-12-19 (AccNo: 0001193125-25-326850)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

19-12-2025

Plum Acquisition Corp IV filed an 8-K on December 19, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties, valuation, or quantitative metrics are explicitly stated in the provided filing summary. Critical information such as transaction value, share counts, and strategic rationale is NOT_DISCLOSED.

• ·Item 7.01: Regulation FD Disclosure – indicates material non-public information release, likely M&A announcement.
• ·Item 9.01: Financial Statements and Exhibits – attachments present but contents NOT_DISCLOSED.
• ·Sector NOT_DISCLOSED; no quantitative data (e.g., transaction value: NOT_DISCLOSED, share count: NOT_DISCLOSED).

19-12-2025

Chevron Corp filed an 8-K on December 19, 2025, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited to the fact of disclosure with all other elements NOT_DISCLOSED.

• ·Item 5.02 event: Covers departures, elections, appointments, or compensatory arrangements
• ·No names, positions (e.g., CEO/CFO), reasons (e.g., retirement), or timing details disclosed
• ·No quantitative data (transaction values, shares, percentages) mentioned: all NOT_DISCLOSED

19-12-2025

Rivian Automotive, Inc. filed an 8-K on December 19, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 filing for officer change (departure, election, appointment, or compensatory arrangements)
• ·Filed 2025-12-19; no names, positions, reasons, or numbers disclosed
• ·Sector not specified

19-12-2025

MONARCH CASINO & RESORT INC filed an 8-K on December 19, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the summary. Analysis limited to filing metadata; critical details NOT_DISCLOSED.

• ·Item 5.02 disclosure on officer/director changes or compensation.
• ·Filed December 19, 2025 (AccNo: 0001104659-25-123193).
• ·No names, positions, reasons, or financial metrics disclosed.

19-12-2025

Cue Biopharma, Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 8.01, and 9.01.
• ·Item 1.01 signals entry into a material definitive agreement, inherently material per SEC rules.
• ·No quantitative data (transaction value, shares, financial metrics) or strategic details disclosed.

19-12-2025

TAO Synergies Inc. filed an 8-K on December 19, 2025, disclosing an officer or director change under Item 5.02, submission of matters to a shareholder vote under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit facts.

• ·Item 5.02 triggered: Departure/election/appointment of directors/officers or compensatory arrangements (details NOT_DISCLOSED)
• ·Item 5.07 triggered: Shareholder vote outcomes (details NOT_DISCLOSED)
• ·Item 9.01 triggered: Exhibits filed (contents NOT_DISCLOSED)

19-12-2025

Okta, Inc. filed an 8-K on December 19, 2025, disclosing an officer change or compensatory arrangement under Item 5.02, with exhibits under Item 9.01. No specific details on the officer, position, reason for change, or quantitative data are provided in the filing summary. Analysis limited to disclosed headers; critical details NOT_DISCLOSED.

• ·Item 5.02: Covers departure/election/appointment of officers or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 9.01: Financial statements and exhibits filed - contents NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED

19-12-2025

Tigo Energy, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001213900-25-123890), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. No details on the agreement's terms, value, parties, or impact are disclosed in the provided summary. Analysis is limited; full filing review required for materiality assessment.

• ·Multi-item 8-K: Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Entry into undisclosed Material Definitive Agreement; all quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED
• ·Timing, compliance, strategic importance, financial impacts, and market reactions NOT_DISCLOSED

19-12-2025

IBEX Ltd filed an 8-K on December 19, 2025, disclosing an Item 5.02 officer change involving departure, election, appointment, or compensatory arrangements of certain officers or directors. No specific names, positions, reasons, or quantitative details are stated in the provided summary. Analysis limited to disclosure facts only; neutral signal pending full filing review.

• ·Item 5.02 indicates unspecified officer/director departure, appointment, or compensatory change
• ·No details on key position (CEO/CFO/etc.), appointment/resignation type, or reasons provided
• ·Filed timely per SEC 8-K requirements within 4 business days

19-12-2025

SM Energy Co filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosed items.

• ·Item 5.02 indicates officer or director change event, including possible compensatory arrangements
• ·Item 7.01 provides Regulation FD disclosure
• ·All specifics (names, positions, reasons, numbers) are NOT_DISCLOSED

19-12-2025

TXNM Energy Inc filed a multi-item 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and Regulation FD disclosure (Item 7.01). No details on the core event, transaction value, terms, or financial metrics are disclosed in the provided summary. Analysis is limited, indicating a potentially significant financing or agreement event requiring review of full filing.

• ·Multi-item mandatory 8-K: Items 1.01, 2.03, 7.01, 9.01 reported.
• ·Core event involves material agreement and financial obligation; all quantitative data NOT_DISCLOSED.
• ·Timing compliance and strategic details unknown from summary.

19-12-2025

INSIGHT ENTERPRISES INC filed an 8-K on 2025-12-19 reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or financial metrics are disclosed in the provided summary. This is a multi-item mandatory filing indicating a material event.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01
• ·Core event: Entry into material definitive agreement creating financial obligation
• ·All quantitative data (transaction value, share count, etc.): NOT_DISCLOSED

19-12-2025

Compass Diversified Holdings filed an 8-K on 2025-12-19 disclosing entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements/Exhibits (Item 9.01). No specific transaction details, financial metrics, or impacts are disclosed in the provided summary. Analysis limited to filing items due to lack of content.

• ·Multi-item 8-K: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·Filed via AccNo: 0001345126-25-000089; timing compliance NOT_DISCLOSED

19-12-2025

SIFCO Industries Inc filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specifics on position, individual, appointment/resignation, or reasons provided in the summary. Analysis limited; quantitative data NOT_DISCLOSED.

• ·Item 5.02 disclosure for unspecified officer change
• ·Filed timely on 2025-12-19 (AccNo: 0001628280-25-058308)
• ·No details on key position, reason, or impacts; sector NOT_DISCLOSED

19-12-2025

MainStreet Bancshares, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosure event; all key facts NOT_DISCLOSED.

• ·Item 5.02 disclosure for officer change, compliant with SEC 8-K requirements (within 4 business days)
• ·No details on key position (e.g., CEO/CFO), appointment/resignation, reasons, or timing provided (NOT_DISCLOSED)
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

19-12-2025

Inmune Bio, Inc. filed an 8-K on December 19, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No details on the agreement's nature, value, or terms are provided in the filing summary. Analysis limited to explicitly stated items; all other data NOT_DISCLOSED.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event is entry into unnamed material agreement
• ·Transaction value, share count, financial metrics: NOT_DISCLOSED

19-12-2025

ProFrac Holding Corp. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), with exhibits attached (Item 9.01). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided summary. This multi-item filing indicates a potentially significant development requiring review of the full document.

• ·Reported Items: 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 9.01 (Exhibits)
• ·Multi-item mandatory 8-K filing on event date (December 19, 2025)
• ·Core event involves a material agreement creating financial obligations; all quantitative details NOT_DISCLOSED

19-12-2025

Ares Commercial Real Estate Corp filed an 8-K on December 19, 2025, reporting Items 1.01 (Entry into a Material Definitive Agreement) and 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement). No specific transaction details, dollar values, or terms are disclosed in the provided summary. This appears to be a mandatory multi-item filing with limited visibility into financial impact.

• ·Multi-item 8-K filing covering Items 1.01 and 2.03.
• ·Core event involves a material agreement and new financial obligation; all quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
• ·No guidance on timing compliance, market reaction, or related filings provided.

19-12-2025

CERO Therapeutics Holdings, Inc. filed an 8-K on December 19, 2025, reporting an officer change under Item 5.02, submission of matters to a shareholder vote under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, vote outcomes, or quantitative data are disclosed in the provided summary. Analysis is limited to filing items only.

• ·Item 5.02 discloses departure/election of officers or directors and compensatory arrangements
• ·Item 5.07 reports shareholder vote results
• ·Item 9.01 lists financial statements and exhibits; no numerical values or specifics extracted (all NOT_DISCLOSED)

19-12-2025

Vine Hill Capital Investment Corp. II filed a Form 8-K on December 19, 2025, reporting multiple events under Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure/Election of Directors/Officers), 5.03 (Amendments to Articles/Bylaws), 8.01 (Other Events), and 9.01 (Exhibits). This is a multi-item mandatory filing with no quantitative details such as transaction values, share counts, or financial metrics disclosed. Analysis limited by absence of filing content beyond item list.

• ·Multi-item 8-K: Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 reported
• ·Core events involve material agreements, equity sales, governance changes; all other specifics NOT_DISCLOSED
• ·Filing timing, financial impacts, and market reactions NOT_DISCLOSED

19-12-2025

PSQ Holdings, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001104659-25-123291), reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing metadata; full content required for deeper insights.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 7.01 (Reg FD Disclosure), 9.01 (Exhibits).
• ·Core event: Entry into material agreement (details NOT_DISCLOSED).
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.

19-12-2025

Eventbrite, Inc. filed a Form 8-K on December 19, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected position, personnel, nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure facts, with all key change details NOT_DISCLOSED.

• ·Item 5.02 filing signals officer-related event (departure, election, appointment, or compensatory arrangement)
• ·Item 9.01 includes financial statements and exhibits (contents NOT_DISCLOSED)
• ·No names, positions, reasons, timing, or quantitative metrics (e.g., shares, compensation) disclosed

19-12-2025

CCC Intelligent Solutions Holdings Inc. filed an 8-K on December 19, 2025, under Item 5.02 disclosing an unspecified officer change involving departure, election, appointment, or compensatory arrangements. No details on key position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. This is a routine SEC disclosure with limited actionable information.

• ·Item 5.02 filing: Covers officer departures, appointments, elections, or compensatory arrangements
• ·No specifics on officer name, position (e.g., CEO/CFO), reason, or timing disclosed
• ·Filed timely per SEC requirements (within 4 business days)

19-12-2025

ScanSource, Inc. filed a Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), termination of another (Item 1.02), and creation of a direct financial obligation (Item 2.03), with exhibits (Item 9.01). No specific details, values, or transaction terms are disclosed in the provided summary. This multi-item filing indicates mixed events requiring review of attached exhibits for impact assessment.

• ·Multi-item 8-K filing: Items 1.01, 1.02, 2.03, and 9.01 reported.
• ·Core events involve new agreement entry, prior agreement termination, and new financial obligation; all details NOT_DISCLOSED.
• ·Filed same day as event date; compliance with 4-business-day window presumed but timing details NOT_DISCLOSED.

19-12-2025

Freshworks Inc. filed an 8-K on December 19, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the officer, position, nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Analysis is limited to the Item 5.02 disclosure, with all other key facts NOT_DISCLOSED.

• ·Item 5.02 filing indicates potential officer or director change or compensatory arrangement.
• ·Filed timely on 2025-12-19 per SEC requirements for 8-K.
• ·No details on position affected, internal/external hire, reasons, or board impact explicitly stated.

19-12-2025

Streamex Corp. filed a Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing with limited visibility into core events.

• ·Multi-item 8-K filing covering Items 1.01, 2.03, 3.02, 8.01, and 9.01; filing date aligns with event but intra-day timing NOT_DISCLOSED.
• ·Core events involve material agreement, new financial obligation, and unregistered equity sales; all quantitative data (value, shares, etc.) NOT_DISCLOSED.
• ·Compliance with 8-K requirements presumed; no forward-looking statements or risk factors detailed in summary.

19-12-2025

Meta Platforms, Inc. filed an 8-K on December 19, 2025, disclosing an officer change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. No specific details on the officer position, nature of change (appointment/resignation), reasons, or compensation are provided. Analysis is limited to filing metadata, with all key facts NOT_DISCLOSED.

• ·Timely 8-K filing under Item 5.02 for officer-related changes
• ·No quantitative data (transaction values, shares, percentages, financial metrics) disclosed
• ·Critical details such as key position affected, reason, or succession type NOT_DISCLOSED

19-12-2025

Tectonic Financial, Inc. filed a Form 8-K on December 19, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 5.02 (Departure/Election of Directors/Officers/Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements/Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, personnel names, or quantitative data provided in the summary. Analysis limited to item descriptions; all financial metrics and impacts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 5.02, 8.01, 9.01 reported
• ·Core events include material agreement and leadership changes (FACTS from items)
• ·No transaction value, share counts, percentages, or financial metrics disclosed (NOT_DISCLOSED)

19-12-2025

Wheels Up Experience Inc. filed an 8-K on December 19, 2025, reporting a Notice of Delisting or Failure to Satisfy Continued Listing Rule (Item 3.01), Regulation FD Disclosure (Item 7.01), and Financial Statements/Exhibits (Item 9.01). This indicates a delisting event from the US market, but specific reasons, timelines, or financial impacts are NOT_DISCLOSED. Multi-item mandatory filing with high materiality due to delisting notice.

• ·Specific Items: 3.01 (Delisting Notice), 7.01 (Reg FD), 9.01 (Exhibits) - multi-item filing.
• ·Core event: Notice of delisting or listing rule failure; all quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.
• ·Compliance: Appears mandatory; timing within same day but 4-hour filing verification NOT_DISCLOSED.

19-12-2025

IO Biotech, Inc. filed an 8-K on December 19, 2025, reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific reasons, financial details, or transaction values are disclosed in the provided filing summary. This indicates a material negative event for US-listed shares.

• ·Item 3.01 reported: Notice of delisting or failure to satisfy listing standards
• ·Single-item 8-K filing (Item 3.01 only)
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

19-12-2025

Firefly Neuroscience, Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits attached (Item 9.01). No specific details on the agreement, transaction value, share count, or financial impacts are disclosed in the provided summary. Analysis is limited due to lack of filing content.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 3.02 (Unregistered Equity Sales), 9.01 (Exhibits)
• ·Core events involve a material agreement and equity sales; all quantitative data (transaction value, share count, etc.) NOT_DISCLOSED
• ·Compliance with 8-K filing assumed; no timing of event or voluntary/mandatory details specified

19-12-2025

Luminar Technologies, Inc. filed an 8-K on December 19, 2025, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on reasons, timelines, or financial impacts are disclosed. This signals potential removal from major US exchanges, increasing illiquidity risks.

• ·Single-item 8-K filing under Item 3.01 only
• ·Event: Notice of delisting or listing rule failure; all quantitative data (transaction value, shares, percentages, financial metrics) NOT_DISCLOSED
• ·Sector not specified; no timing, compliance, or related filings details provided

19-12-2025

Verastem, Inc. filed an 8-K on December 19, 2025, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), alongside Regulation FD Disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer, position, reason, or quantitative data are disclosed in the filing summary. Analysis is limited to disclosure of a leadership event without further context.

• ·Item 5.02 indicates departure, election, appointment, or compensatory arrangements for officers/directors
• ·Item 7.01: Regulation FD Disclosure, potentially material non-public information
• ·Item 9.01: Financial Statements and Exhibits filed; Accession No. 0001104659-25-123295

19-12-2025

Playboy, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001628280-25-058362) disclosing under Item 3.01 a notice of delisting or failure to satisfy continued listing rules, and under Item 5.02 changes in directors or officers. No specific details on delisting reasons, transaction values, or officer identities are provided in the summary. This indicates potential liquidity and leadership risks for US equity investors.

• ·Multi-item 8-K filing reporting Items 3.01 (delisting notice) and 5.02 (director/officer changes).
• ·Core event: Notice of delisting or listing rule failure; officer departures/appointments.
• ·No quantitative data (e.g., transaction values, share counts) disclosed.

19-12-2025

IN8BIO, INC. filed a Form 8-K on December 19, 2025 (AccNo: 0001193125-25-327097), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, or quantitative data disclosed in the summary. Core events involve a material agreement and equity sales, but impacts are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 3.02, 9.01 reported
• ·Core events: Material definitive agreement and unregistered equity sales (details NOT_DISCLOSED)
• ·No quantitative data: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED